We are doing some updates to our web server on Friday, October 6 that may result in the CTN Dissemination Library website and resources being unavailable for several hours between 8am-5pm PT. If you try to access the site and it’s down, try again in a few hours. If you need a resource immediately, please email the CTN Dissemination Librarian (Meg Brunner) at meganw@uw.edu and I can try to pull it for you!

The CTN Library’s What’s New blog provides updates on CTN Nodes and Protocols, news from NIDA, funding information/opportunities, invitations to CTN-related events and webinars, and more! (Submit your CTN-related content for the blog and the CTN Bulletin to us at ctnlib@uw.edu!) Tired of having to come to the site to see if any new posts are available? Sign up here to get our posts via email instead!

The Learning for Early Careers in Addiction and Diversity (LEAD) Program provides training to early-career research scientists from racial/ethnic minoritized groups that are underrepresented in the substance use and substance use disorder research field. [download/share flyer, updated 9/15/2023] The program uses the NIDA Clinical Trials Network (CTN) as a platform for training early-career investigators. This 3-year training program is based at the University of California, San Francisco (UCSF), and visiting scholars spend three summers in a 4-week intensive program at UCSF. During the academic year, scholars work with their primary mentor to collaborate on substance use and substance use disorder treatment research conducted in the CTN, develop a professional research…

The Journal of Substance Use & Addiction Treatment (JSAT) is seeking abstracts for a special issue on addiction treatment implementation research, including: quantitative research, theory-driven or -generating qualitative studies, study protocols, systematic reviews, and meta-analyses. One-page abstracts of the proposed paper are due by November 1, 2023, and must be submitted to Dr. Mark McGovern at mpmcg@stanford.edu. (Reminder that all CTN-related papers have to be approved by the Publications Subcommittee before being submitted for publication!  Please email Susan Sonne (sonnesc@musc.edu) and Jack Blaine (jblaine@nida.nih.gov) for more information.) Find more details about the JSAT submission here.

(From the US FDA press release) Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose. Today’s action paves the way for the life-saving medication to reverse an opioid overdose to be sold directly to consumers in places like drug stores, convenience stores, grocery stores and gas stations, as well as online.  Read the complete press release. Posted March 29, 2023

January 25, 2023 NIDA International Program is accepting applications for international postdoctoral researchers for the INVEST Drug Use and Addiction Research Fellowship. This combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug use and addiction scientists. Fellowship: The 12-month INVEST fellowship provides rigorous postdoctoral research training with a NIDA grantee at a U.S. institution, professional development activities that help establish personal relationships with NIDA grantees and NIDA officials, a stipend for living and personal expenses, and an allowance to cover the cost of health insurance and professional development activities. Eligibility: INVEST applicants are required to be international researchers with a doctoral…